Advertisement
Sunday, Jan 23, 2022
Outlook.com
Outlook.com

Sun Pharma Advanced Research Enters Licensing Agreement With Biomodifying For Oncology Antibodies

Sun Pharma Advanced would now have the right to license Biomodifying's intellectual property, including all its patents and patent application along with antibodies, including that for cancer ailment.

Sun Pharma Advanced Research Enters Licensing Agreement With Biomodifying For Oncology Antibodies
Sun Pharma Advanced Research Enters Licensing Agreement With Biomodifying For Oncology Antibodies
outlookindia.com
2021-12-03T15:50:24+05:30

Sun Pharma Advanced Research Company announced on Friday that it has entered into a licensing agreement with cancer drug maker Biomodifying. As per the license agreement, Sun Pharma Advanced Research would acquire the right to license the biotech company's intellectual property, including all its patents and patent application along with antibodies developed for multiple purposes, including that of cancer ailment. 

Licensing agreement for intellectual property refers to an agreement under which the IP-owner retains ownership of their patent or trademark but gives another company permission to use the same for a specific period of time for a royalty or a payment.

The biotech cancer drug maker would be eligible for an up-front payment, milestone payments on pre-specified clinical, regulatory and commercial milestones and royalties derived from sales. Additionally, Sun Pharma Advanced Research would pay Biomodifying a percentage of payments acquired from sublicensing of the company's intellectual property. 

“This is an important milestone for SPARC. The licensing of antibodies from Biomodifying will assist us in our endeavour to transition SPARC into a company focussed on novel treatment modalities, including bi-specific antibodies and antibody-drug conjugates" said the CEO of Sun Pharma Advanced Research, Anil Raghavan. 

At the time of publishing, the company's stock was trading 2.56 per cent higher at Rs 254.85 on the BSE. On the NSE, the stock was 2.47 per cent up at Rs 255.00. 

Sun Pharma Advanced Research was emerged from Sun Pharmaceuticals to become a dedicated company for research and drug discovery in 2007. 

Advertisement

Outlook Newsletters

Advertisement
Advertisement
Advertisement

Read More from Outlook

Lament Of Separation: Songs Of Habba Khatun, Last Queen Of Kashmir, Still Echo In Valley

Lament Of Separation: Songs Of Habba Khatun, Last Queen Of Kashmir, Still Echo In Valley

In happy times and sad, Habba Khatun’s sensuous songs make both young and old emotional. With the never-ending conflict bringing tragedies to every doorstep, Habba’s lyrics of separation amplify their mourning.

How Indian Laws Govern People’s Right To Love And Live

How Indian Laws Govern People’s Right To Love And Live

In India, only those relationships between a man and a woman are considered to be legitimate when there is a marriage between the two.

Kohli Quits Test Captaincy, Leaves Leadership Vacuum

Kohli Quits Test Captaincy, Leaves Leadership Vacuum

Virat Kohli, 33, had recently stepped down as India's T20I captain and was subsequently removed as the ODI captain.

UP Elections 2022: How Congress Is Harnessing Power Of 'Persecuted' Women To Counter BJP

UP Elections 2022: How Congress Is Harnessing Power Of 'Persecuted' Women To Counter BJP

A Mahila Congress leader, who is the face of the ‘Ladki Hoon, Lad Sakti Hoon’ campaign, however, has accused the party of anti-women bias after she was denied a ticket.

Advertisement